首页 | 本学科首页   官方微博 | 高级检索  
检索        

黄芩汤对非酒精性脂肪肝炎大鼠的作用及机制研究
引用本文:严宝飞,戴仕林,刘圣金,刘嘉,王从成,平凡.黄芩汤对非酒精性脂肪肝炎大鼠的作用及机制研究[J].中国医院药学杂志,2022,42(10):1009-1014.
作者姓名:严宝飞  戴仕林  刘圣金  刘嘉  王从成  平凡
作者单位:1. 1. 江苏卫生健康职业学院药学院, 江苏 南京 211800;2. 南京中医药大学江苏省中药资源产业化过程协同创新中心/中药资源产业化与方剂创新药物国家地方联合工程研究中心/国家中医药管理局中药资源循环利用重点研究室, 江苏 南京 210023
基金项目:江苏省高校“青蓝工程”优秀教学团队培养对象(编号:苏教师[2020]42号);江苏省中医药科技发展计划项目(编号:YB2020100);江苏卫生健康职业学院校级课题重点项目(编号:JKB202003)
摘    要:目的:研究黄芩汤对非酒精性脂肪肝炎(non-alcoholic steatohepatitis,NASH)的作用及机制。方法:将大鼠随机分为空白组、模型组、阳性对照组(多烯磷脂胆碱,8 mg·kg-1)、黄芩汤低、中、高剂量组(5,10,20 g·kg-1),采用高脂饮食饲喂12周造模。灌胃给药5周后,检测各组大鼠血脂、肝功能及炎性因子水平;HE染色观察肝脏组织病理变化;RT-PCR和Western Blot法检测肝组织Toll样受体2(TLR2)、髓样分化因子88(MyD88)、核因子κB p65(NF-κB p65)、白介素6(IL-6)、维甲酸相关核孤儿受体γt(RORγt)、IL-23IL-17 mRNA和蛋白表达;免疫组化法检测肝组织中NF-κB p65表达。结果:与空白组比较,模型组大鼠血脂、肝功能和炎性因子水平明显异常(P<0.01)。肝组织出现脂肪变性及炎性浸润;肝组织中TLR2MyD88NF-κB p65IL-6RORγtIL-23IL-17 mRNA和蛋白表达明显升高(P<0.01);NF-κB p65阳性细胞表达明显提升(P<0.01)。与模型组比较,黄芩汤组大鼠血脂、肝功能和炎性因子水平得到明显恢复(P<0.05,P<0.01);肝组织脂肪变性和炎性浸润得到纠正;上述蛋白mRNA和蛋白表达均明显降低(P<0.05,P<0.01);NF-κB p65阳性细胞表达明显降低(P<0.01)。结论:黄芩汤可能通过抑制TLR2/MyD88/NF-κB信号通路和IL-23/IL-17轴治疗NASH。

关 键 词:黄芩汤  非酒精性脂肪肝炎  TLR2/MyD88/NF-κB信号通路  IL-23/IL-17轴  
收稿时间:2021-09-28

Study on the effect and mechanism of Huangqin Decoction in non-alcoholic steatohepatitis rats
YAN Bao-fei,DAI Shi-lin,LIU Sheng-jin,LIU Jia,WANG Cong-cheng,PING Fan.Study on the effect and mechanism of Huangqin Decoction in non-alcoholic steatohepatitis rats[J].Chinese Journal of Hospital Pharmacy,2022,42(10):1009-1014.
Authors:YAN Bao-fei  DAI Shi-lin  LIU Sheng-jin  LIU Jia  WANG Cong-cheng  PING Fan
Abstract:OBJECTIVE To study the effect and mechanism of Huangqin Decoction on the non-alcoholic steatohepatitis (NASH) in rats.METHODS The experimental groups were fed with high-fat diet for 12 weeks to develop an animal model for NASH. The rats were randomly divided into six groups,including normal,model,polyene lecithin choline-treated (8 mg·kg-1),Huangqin Decoction-treated (low-dose,5 g·kg-1),Huangqin Decoction-treated (medium-dose,10 g·kg-1) and Huangqin Decoction-treated (high-dose,20 g·kg-1). After 5 weeks of oral administration,the levels of blood lipid,liver function and inflammatory factors were detected. Meanwhile,the pathological changes of liver tissues were analyzed by HE staining. RT-PCR and western blot were used to analyse the expression of toll-like receptor 2 (TLR2),myeloid differentiation factor 88 (MyD88),nuclear factor kappa-B p65 (NF-κB p65),interleukin 6 (IL-6),retinoid-related orphan nuclear receptor γt (RORγt),IL-23 and IL-17. Then the expression level of NF-κB p65 in liver tissue was detected by immunohistochemical staining.RESULTS Compared with the normal group,the blood lipid profiles,liver function and the level of inflammatory cytokines in the model group were abnormal (P<0.01). The liver tissue in the model group showed severe steatosis with inflammatory infiltration. The mRNA and protein expressions of TLR2,MyD88,NF-κB p65,IL-6,RORγt,IL-23 and IL-17 in the model group were significantly increased (P<0.01); the expression of NF-κB p65 positive cells in the the model group was significantly increased (P<0.01). Compared with the model group,the blood lipid profiles,liver function and the level of inflammatory cytokines were obviously recovered in Huangqin Decoction groups (P<0.05,P<0.01). Liver tissue steatosis and inflammatory infiltration in Huangqin Decoction groups were corrected. The mRNA and protein expressions level in Huangqin Decoction groups were significantly decreased (P<0.05,P<0.01),and the expression of NF-κB p65 positive cells in Huangqin Decoction groups was significantly increased (P<0.01).CONCLUSION Huangqin Decoction might treat NASH through the TLR2/MyD88/NF-κB signaling pathway and IL-23/IL-17 axis.
Keywords:Huangqin Decoction  non-alcoholic steatohepatitis  TLR2/MyD88/NF-κB signaling pathway  IL-23/IL-17 axis  
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号